Company intelligence / Profile preview

Valuebiotech

Ownership: Private
Development stage: Commercial

Overview

Valuebiotech has developed a patented robotic platform for minimally invasive, scar-free abdominal surgery via natural orifices. The M.I.L.A.N.O. robot features advanced 3D visualization and computerized supervision to enhance patient safety and reduce recovery time. As of the latest information, it is in prototype/laboratory testing with plans for further development and international commercialization.

Therapeutic areas: Gastroenterology
Modalities: DeviceRobotic surgery platform (M.I.L.A.N.O. Robotic Platform)
Industry: Surgical Medical Devices

Partnerships

Distribution agreements signed for Europe, China, Japancontracts with Italian research institutes and small/medium firmsinvestment from Azimut Holding since 2021

Beyond the preview

Go deeper on Valuebiotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Valuebiotech.

Explore the full profile